Skip to main content
. 2014 Dec 5;17(1):19164. doi: 10.7448/IAS.17.1.19164

Figure 2.

Figure 2

Yearly transmitted drug resistance prevalence (A–C) and absolute number (D–F) of yearly TDR cases by antiretroviral treatment initiation threshold, by patient monitoring strategy, over a period of 10 years. Panel A and D refer to when all monitoring strategies are implemented in combination with treatment initiation at CD4 <350 cells/µl, panel B and E in combination with treatment initiation at CD4 <500 cells/µl, and panel C and F in combination with immediate treatment. VL = viral load testing.